capping insulin at just $35 a month
Cap insulin at $35 a month.
Occurrences
Evidence
Stanton's official House health-care page says he supports "capping insulin at just $35 a month" as part of his health agenda.
After House passage of the Inflation Reduction Act, Stanton said Congress had delivered on promises to cut drug costs and that he had pushed to let Medicare use negotiating power to lower prescription drug prices since his first day in Congress.
The House roll call for H.R. 5376 shows Rep. Greg Stanton (AZ) voted Yea on the Build Back Better Act vote that preceded the final Inflation Reduction Act package.
CMS says the Inflation Reduction Act ensures people with Medicare pay no more than $35 for a month’s supply for each covered insulin product under Medicare prescription drug coverage, Traditional Medicare, or Medicare Advantage.
Assessments
The federal outcome during Stanton's 2021-2023 House term was a real $35 monthly insulin cap, enacted through the Inflation Reduction Act in August 2022, but it applied to Medicare-covered insulin rather than all insulin users. Stanton was in office at the time and supported the relevant Democratic drug-cost legislation, so he gets candidate credit for materially advancing the partial outcome, but the broader promise was not fully delivered universally.